Ultromics

Could AI diagnose your heart disease? In a new study, an AI model outperformed current clinical scoring systems for accurately detecting and identifying cardiac amyloidosis, potentially helping doctors give patients earlier, more effective treatments. uchicagomedicine.org/forefront/rese…

New multi-center validation in #JACCAdvances compared multiple algorithms for detecting Cardiac #Amyloidosis. EchoGo® Amyloidosis demonstrated the highest sensitivity and accuracy (AUC 0.92). See paper: sciencedirect.com/science/articl… The study highlights the growing role of AI in…

Mayo Clinic and Ultromics' AI-powered echocardiography detects cardiac amyloidosis, a life-threatening heart condition, with high sensitivity and accuracy. Early detection is key. Learn more: mayocl.in/44Etbii

Exciting to see a new study examining this @US_FDA cleared, #AI-powered, #CardiacAmyloidosis screening tool from @Ultromics. Improving rate, time to, & accuracy of diagnosis is of major importance to improving patient outcomes. Read more in the European Heart Journal:

So grateful to be part of this amazing team of investigators. This project took a village, spanning 19 medical centers & 4 continents. Particular thanks to @robertomlang (in memorium) @pattypellikka, & the amazing @ultromics team for their tireless work, support, and mentorship

Just published in European Heart Journal — a global milestone in AI-powered cardiac care. @UChicagoMed’s Drs. Jeremy Slivnick and Roberto Lang (in memoriam) helped lead a multi-center, international study — in collaboration with Dr. Patricia Pellikka (Mayo Clinic) and the…

📢 New #EHJ study! Our AI screening tool for echo — EchoGo® Amyloidosis — detects cardiac amyloidosis, a life-threatening condition, with high accuracy. Developed with @MayoClinic @UChicago, tested with 18 global sites. See paper & release: ultromics.com/press-releases… #CardioTwitter

📢 New @ASE360 Guidelines on Diastolic Function are out, and Ultromics is cited! Our study on EchoGo® Heart Failure is referenced, highlighting its role in supporting #HFpEF detection from a single echo view. Full guidelines: onlinejase.com/article/S0894-… #CardioTwitter #EchoFirst

We will be at the Charleston HFpEF Conference showcasing our EchoGo® Heart Failure and Amyloidosis modules, the first AI-based tools capable of detecting #HFpEF & #Amyloidosis from routine echocardiograms. ultromics.com/about/events

“I think EchoGo® Amyloidosis is going to be very important because we have data that suggest a significant number of patients with HFpEF can have underlying cardiac amyloidosis" Learn more about EchoGo® Amyloidosis in a new interview with Dr. Andres Schuster at @HarringtonHVI:…

In a new interview, Dr. Andres Schuster at @HarringtonHVI discusses recent cases where EchoGo® Amyloidosis supported the positive identification of patients with cardiac amyloidosis. Learn more how EchoGo® Amyloidosis, powered by #AI, identifies cardiac #amyloidosis, supporting…

EchoGo® Heart Failure detects #HFpEF with excellent sensitivity and specificity. Learn more about its impressive clinical performance in the new interview with Dr. Andres Schuster from @HarringtonHVI in this month’s Cath Lab Digest: hubs.la/Q03rTSzs0 #EchoFirst

Patient symptoms aren’t matching the diastology? EchoGo® Heart Failure can help in the diagnostic process. Dr. Andres Schuster from @HarringtonHVI shares his experience using EchoGo® Heart Failure, powered by AI, to help detect #HFpEF. Read more in Cath Lab Digest:…